Canvassing for Opinion - aka "Blairs Brain on Cannabis"

IMHO prohibition sentiment requires inherent addiction to status quo, an incapacity to visualise beyond the here and now and a desperate desire to know others might feel the same... Reform is not revolutionary, rather it is evolutionary. Having survived banging your head against a brick wall the evolutionist relishes having stopped. / Blair

Friday, September 01, 2006

Extract of interest to blind policy makers

Dr. Pate who was kind enough to provide AAMC with his doctoral dissertation on anandamide (the bodies natural THC) and glaucoma, proceeded to describe a model of glaucoma that raised many new questions. What if the painful intra-ocular pressures present in glaucoma were not the cause of the disease but the symptom of underlying neuroinflammation?

Presenting elegant experimental data, Dr. Pate demonstrated that indeed key nerves involved in the "gating" of fluids within the eye were inflamed in glaucoma and that such inflammation could be countered by anandamide.

It shouldn't be surprising that CB1 receptors were identified by Dr. Pate within the eye. Binding to these sites reduced inflammation and reduced painful pressure. Cannabinoids are seen by Dr. Pate as providing an "ocular stabilizing" effect helping to prevent the inflammation of nerves within the eye. A significant volume of work supports Dr. Pate's findings including that of Dr. R. Ritch from the Department of Ophthalmology, New York Eye and Ear Infirmary. In a recently published article Dr. Ritch answers the question:

"Neuroprotection: is it already applicable to glaucoma therapy? Many categories of both natural and synthetic compounds have been reported to have neuroprotective activity. These include not only antioxidants, N-methyl-D-aspartate receptor antagonists, inhibitors of glutamate release, calcium channel blockers, polyamine antagonists, and nitric oxide synthase inhibitors, but cannabinoids, aspirin, melatonin, and vitamin B-12.

The lack of availability of specific neuroprotectant compounds in the United States and the lack of clinical trials examining the benefits of neuroprotective agents for glaucoma currently limit the use of these agents.

This article provides a short overview of the concept of neuroprotection as it applies to glaucoma and suggests the possibility of neuroprotective activity that might be provided by compounds that are presently easily available."

Cannabinoids, the active ingredients in cannabis, have many distinct pharmacological properties. These include analgesic, anti-emetic, anti-oxidative, neuroprotective, and anti-inflammatory actions see: (

Any and all required research programs in New Zealand would, according to procedure and protocols be required to pass POLICE scrutiny before it could be approved as would, it would seem the status of the research subject. (see NORML NZ website)
One couldn't have criminals getting healthy of their own accord else putting Neville Yates [and others] in jail would have been morally wrong.
The word, 'b'stards' comes to mind....

Blair Anderson
ph (643) 389 4065 cell 027 265 7219
View blog reactions


Post a Comment

Links to this post:

Create a Link

<< Home


Another Mild Green Initiative

  (search tips)

Visitor Map
Visitor Map, daily!

Visitor Map, previous 6 months

MildGreen Technorati Search
Web Blog Pinging Service Blog Flux Directory Blogarama - The Blog Directory Find Blogs in the Blog Directory Search For Blogs, Submit Blogs, The Ultimate Blog Directory Health Blog Top Sites Google PageRank Checker Tool Top Blogs Health blogs